Alzheimer's disease is the most common chronic neurodegenerative disease clinically characterized by a progressive impairment of cognitive function. The neurochemical parameter best correlated with cognitive dysfunction is the level of soluble β-amyloid peptide. Experimental evidence suggests that caffeine afford a robust protection against β-amyloid peptide toxicity. We discuss the mechanisms through which caffeine prevents cerebral β-amyloid peptide toxicity.
Caffeine protection against β-amyloid peptide toxicity in Alzheimer’s disease
CHIEFFI, Sergio;LA MARRA M;MESSINA G;MONDA, Marcellino
2011
Abstract
Alzheimer's disease is the most common chronic neurodegenerative disease clinically characterized by a progressive impairment of cognitive function. The neurochemical parameter best correlated with cognitive dysfunction is the level of soluble β-amyloid peptide. Experimental evidence suggests that caffeine afford a robust protection against β-amyloid peptide toxicity. We discuss the mechanisms through which caffeine prevents cerebral β-amyloid peptide toxicity.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
